×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Clinical: PDR-001 Alpha-Synuclein Removal PD Trial
clinical
868 words
KG: OVERVIEW
2026-03-28
kind:clinical-trial
section:clinical-trials
topic:parkinsons
Contents
PDR-001 Alpha-Synuclein Removal PD Trial
Knowledge Graph
Related Hypotheses (6)
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
Lysosomal Enzyme Trafficking Correction
Score: 0.49
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.49
Lysosomal Membrane Repair Enhancement
Score: 0.45
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.43
Show 1 more
Related Analyses (2)
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Related Experiments (1)
Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40
Knowledge Graph (12 edges)
OVERVIEW
biomarker_for
BRAF
OVERVIEW
biomarker_for
ATRX
OVERVIEW
activates
VALOSIN
OVERVIEW
therapeutic_target
CXCR1
OVERVIEW
regulates
LETM1
OVERVIEW
regulates
MCU
OVERVIEW
activates
CHMP2B
OVERVIEW
activates
TARDBP
OVERVIEW
activates
LC3
OVERVIEW
activates
TBK1